Peyronie's Disease

A condition characterized by the development of fibrous scar tissue inside the penis, causing curved and painful erections

Quick Facts

Prevalence

3-9% of men

Common Age

40-70 years

Duration

Chronic condition

ICD-10 Code

N48.6

Overview

Peyronie's disease is a connective tissue disorder involving the growth of fibrous plaques in the soft tissue of the penis. This condition affects the tunica albuginea, the thick elastic membrane that helps keep the penis rigid during erection. As scar tissue forms, it can cause the penis to bend or curve during erections, often resulting in pain and difficulty with sexual intercourse.

The disease typically develops in two phases: an acute inflammatory phase lasting 6-18 months, during which plaque forms and stabilizes, followed by a chronic phase where the plaque becomes fibrotic and calcified. During the acute phase, men often experience pain with erections and notice progressive penile deformity. The chronic phase is characterized by stable deformity with less pain but potential erectile dysfunction.

While Peyronie's disease can occur at any age, it most commonly affects middle-aged men. The psychological impact can be significant, affecting self-esteem, relationships, and quality of life. Fortunately, various treatment options are available, ranging from conservative management to surgical intervention, depending on the severity and impact of the condition.

Symptoms

Disease Phases

  • Acute Phase: Pain, developing curvature, soft plaque
  • Chronic Phase: Stable curvature, hard plaque, minimal pain
  • Progression: Symptoms may worsen, stabilize, or rarely improve
  • Complications: Severe curvature preventing intercourse

Important Note

The degree of curvature can vary significantly, from mild (less than 30 degrees) to severe (greater than 60 degrees). Not all men with Peyronie's disease experience all symptoms.

Causes

The exact cause of Peyronie's disease remains unclear, but research suggests it results from repeated penile injury or trauma that leads to abnormal wound healing. This creates scar tissue formation in the tunica albuginea.

Primary Mechanisms

  • Microtrauma theory: Repeated minor injuries during sexual activity or physical activities cause small tears in the tunica albuginea
  • Abnormal healing response: In susceptible individuals, normal healing is disrupted, leading to excessive scar tissue formation
  • Genetic factors: Certain genetic variations may predispose individuals to abnormal wound healing and fibrosis
  • Autoimmune component: Some research suggests an autoimmune response may contribute to plaque formation

Contributing Factors

  • Penile trauma: Direct injury to the erect or flaccid penis
  • Vigorous sexual activity: Positions or practices that bend the erect penis
  • Medical procedures: Catheterization, cystoscopy, or prostate surgery
  • Connective tissue disorders: Dupuytren's contracture, plantar fibromatosis
  • Vascular factors: Poor blood flow may impair healing
  • Age-related changes: Decreased elasticity of penile tissues with aging

Molecular Pathways

Research has identified several molecular pathways involved in Peyronie's disease development:

  • Transforming growth factor-beta (TGF-β) overexpression
  • Abnormal collagen deposition and cross-linking
  • Myofibroblast activation and persistence
  • Oxidative stress and free radical damage
  • Aberrant inflammatory response

Risk Factors

Several factors increase the likelihood of developing Peyronie's disease:

Demographic Factors

  • Age (highest risk between 40-70 years)
  • Caucasian ethnicity
  • Family history of Peyronie's disease
  • Genetic predisposition to fibrotic disorders

Medical Conditions

Lifestyle and Other Factors

  • Smoking (impairs wound healing)
  • History of penile trauma
  • Certain sexual practices
  • Previous pelvic surgery
  • Prostate cancer treatment
  • Low testosterone levels

Diagnosis

Diagnosis of Peyronie's disease typically involves a thorough medical history, physical examination, and sometimes imaging studies to assess the extent of the condition.

Clinical Evaluation

  • Medical history: Onset of symptoms, progression, impact on sexual function, associated conditions
  • Physical examination: Palpation of penile plaques, assessment of deformity
  • Stretched penile length: Measurement to document baseline and monitor changes
  • Photographic documentation: Images of erect penis to assess curvature angle

Assessment Methods

Duplex Ultrasound

Evaluates plaque location, penile blood flow, and vascular function

Intracavernosal Injection

Induces erection for accurate assessment of deformity

MRI (rarely needed)

Detailed imaging for complex cases or surgical planning

Questionnaires

PDQ (Peyronie's Disease Questionnaire) to assess impact

Partner Assessment

Understanding impact on sexual relationship

Erectile Function Tests

IIEF questionnaire to evaluate erectile dysfunction

Differential Diagnosis

Conditions to rule out include:

  • Congenital penile curvature
  • Penile fracture sequelae
  • Chordee
  • Penile cancer
  • Thrombosed dorsal vein

Treatment Options

Treatment for Peyronie's disease depends on the phase of the disease, severity of symptoms, and impact on sexual function. The goal is to reduce pain, correct deformity, and restore sexual function.

Conservative Management

For mild cases or during the acute phase:

  • Observation: Monitoring for spontaneous improvement (rare but possible)
  • Pain management: NSAIDs for discomfort during acute phase
  • Psychological support: Counseling for emotional impact
  • Partner education: Understanding and adapting to changes

Medical Treatments

Oral Medications

  • Vitamin E (limited evidence)
  • Potassium aminobenzoate (Potaba)
  • Colchicine (anti-inflammatory)
  • Pentoxifylline (improves blood flow)
  • PDE5 inhibitors for erectile dysfunction

Intralesional Injections

  • Collagenase (Xiaflex): FDA-approved enzyme that breaks down plaque
  • Verapamil: Calcium channel blocker
  • Interferon α-2b: Reduces fibrosis
  • Corticosteroids: Limited use due to side effects

Non-invasive Therapies

  • Penile traction therapy
  • Vacuum erection devices
  • Extracorporeal shockwave therapy
  • Iontophoresis (electrical drug delivery)

Surgical Treatment

Reserved for stable disease (>12 months) with significant deformity:

  • Nesbit procedure: Shortening the longer side of the penis
  • Plaque incision/excision and grafting: For severe curvature or hourglass deformity
  • Penile prosthesis: For concurrent severe erectile dysfunction
  • Plication techniques: Various methods to correct curvature

Emerging Treatments

  • Stem cell therapy
  • Gene therapy approaches
  • Novel anti-fibrotic agents
  • Combination therapies

Prevention

While Peyronie's disease cannot always be prevented, certain measures may reduce the risk of developing the condition or minimize its progression:

Injury Prevention

  • Avoid sexual positions that excessively bend the erect penis
  • Use adequate lubrication during sexual activity
  • Be cautious during vigorous sexual activity
  • Seek immediate medical attention for penile trauma
  • Avoid activities that risk penile injury

Health Management

  • Control underlying conditions like diabetes and hypertension
  • Maintain cardiovascular health through diet and exercise
  • Quit smoking to improve tissue healing
  • Manage cholesterol levels
  • Address erectile dysfunction promptly

Early Intervention

  • Seek medical evaluation at first signs of penile changes
  • Document progression with photographs
  • Consider early treatment during acute phase
  • Regular follow-up with urologist

When to See a Doctor

Consult a healthcare provider, preferably a urologist, if you experience:

Seek Immediate Care For

  • Sudden severe penile pain or trauma
  • Inability to urinate
  • Signs of penile fracture (popping sound, immediate swelling)
  • Severe bleeding from the penis

Schedule an Appointment For

  • Noticeable bend or curve in the penis
  • Pain during erections
  • Difficulty with sexual intercourse
  • Palpable lumps or hard areas in the penis
  • Changes in penile length or girth
  • New or worsening erectile dysfunction
  • Emotional distress related to penile changes

Remember

Early diagnosis and treatment can help prevent progression and improve outcomes. Don't let embarrassment prevent you from seeking help.

References

  1. Nehra A, et al. (2023). "Peyronie's Disease: AUA Guideline." Journal of Urology.
  2. Chung E, et al. (2023). "Peyronie's disease: what's new in the field." Therapeutic Advances in Urology.
  3. European Association of Urology. (2023). "EAU Guidelines on Penile Curvature."
  4. Levine LA, Burnett AL. (2023). "Standard Operating Procedures for Peyronie's Disease." Journal of Sexual Medicine.
  5. Ziegelmann MJ, et al. (2023). "Peyronie's disease: Review of etiology, diagnosis, and management." Cleveland Clinic Journal of Medicine.
  6. International Society for Sexual Medicine. (2023). "Peyronie's Disease Committee Report."

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. If you suspect you have Peyronie's disease, consult with a qualified urologist for proper evaluation and treatment. Early intervention can improve outcomes and quality of life.